Drug development targeting the glycogen synthase kinase-3β (GSK-3β)-mediated signal transduction pathway: role of GSK-3β in adult brain
A Takashima - Journal of pharmacological sciences, 2009 - Elsevier
Glycogen synthase kinase-3β (GSK-3β) is a constitutively active kinase. Since its activation
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain.
A Takashima - Journal of Pharmacological Sciences, 2009 - europepmc.org
Glycogen synthase kinase-3beta (GSK-3beta) is a constitutively active kinase. Since its
activation results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease …
activation results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease …
Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Role of GSK-3β in Adult Brain
A Takashima - Journal of Pharmacological Sciences, 2009 - jstage.jst.go.jp
Glycogen synthase kinase-3β (GSK-3β) is a constitutively active kinase. Since its activation
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
[PDF][PDF] Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Role of GSK-3β in Adult Brain
A Takashima - J Pharmacol Sci, 2009 - scholar.archive.org
Glycogen synthase kinase-3β (GSK-3β) is a constitutively active kinase. Since its activation
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
Drug Development Targeting the Glycogen Synthase Kinase-3. BETA.(GSK-3. BETA.)-Mediated Signal Transduction Pathway: Role of GSK-3. BETA. in Adult Brain
A Takashima - Journal of Pharmacological Sciences, 2009 - jlc.jst.go.jp
Glycogen synthase kinase-3β (GSK-3β) is a constitutively active kinase. Since its activation
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain
A Takashima - Journal of pharmacological sciences, 2009 - pubmed.ncbi.nlm.nih.gov
Glycogen synthase kinase-3beta (GSK-3beta) is a constitutively active kinase. Since its
activation results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease …
activation results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease …
Drug Development Targeting the Glycogen Synthase Kinase-3. BETA.(GSK-3. BETA.)-Mediated Signal Transduction Pathway: Role of GSK-3. BETA. in Adult Brain
A Takashima - Journal of Pharmacological Sciences, 2009 - jlc.jst.go.jp
Glycogen synthase kinase-3β (GSK-3β) is a constitutively active kinase. Since its activation
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Role of GSK-3β in Adult Brain
A Takashima - Journal of Pharmacological Sciences, 2009 - jstage.jst.go.jp
Glycogen synthase kinase-3β (GSK-3β) is a constitutively active kinase. Since its activation
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …
results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains …